login
login

Europe Daily Bulletin No. 7814

6 October 2000
Contents Publication in full By article 52 / 54
ECONOMIC INTERPENETRATION / (eu) medical

ORGANON, the human healthcare business of the Dutch-Swedish pharmaceutical and chemicals group AKZO NOBEL, is to invest 44 million euro in two pharmaceutical product plants in the United States. Furthermore, AKZO NOBEL is in search of a taker for its diagnostics business ORGANON TEKNIKA (530 million euro turnover in 1999). AKZO NOBEL is also said to be considering merging it with the diagnostics branch of another group.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION